Current studies on uterine leiomyoma and inflammation [7, 8] focus on inflammatory factors such as interleukin-4 (IL-4), IL-5, IL-10, and IL-13, and evidence regarding the relationship between neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) in patients with uterine leiomyomas is limited. This evidence concerns the gene IL5 and Uterine leiomyoma.